These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 13127100)

  • 1. Post-Kala-Azar dermal leishmaniasis; a report of two typical cases with special reference to result of intensive antimonial therapy.
    TZU-TA C; PANG-MU C; LEE-SHIH L
    Chin Med J; 1953; 71(5):334-42. PubMed ID: 13127100
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of post-kala-azar dermal leishmaniasis with methyl glucamine antimoniate.
    SEN GUPTA PC; BHATTACHARYYA B; DAS AK; SANYAL NN
    J Trop Med Hyg; 1952 Sep; 55(9):205-8. PubMed ID: 13011855
    [No Abstract]   [Full Text] [Related]  

  • 3. On the toxicity of some organic antimonial drugs used for the treatment of kala-azar.
    BOSE AN; GHOSH TN
    Ind Med Gaz; 1946 Jan; 81(1):13-6. PubMed ID: 21025569
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the treatment of 25 cases of kala-azar with stibatin (sodium antimony gluconate).
    CHOUDHURI RK
    Ind Med Gaz; 1946; 81(4-5):174-6. PubMed ID: 20291436
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).
    Thakur CP
    Trans R Soc Trop Med Hyg; 1984; 78(3):391-8. PubMed ID: 6087515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agranulocytosis following antimony therapy in kala-azar.
    BRAHMACHARI PN; MAITI CR; KAR CC
    J Indian Med Assoc; 1955 Oct; 25(10):408-10. PubMed ID: 13278551
    [No Abstract]   [Full Text] [Related]  

  • 7. A new sodium antimony gluconate for the treatment of kala-azar.
    DASTIDAR SK
    J Indian Med Assoc; 1945 Sep; 14():298. PubMed ID: 21003768
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium antimony v. gluconate in the treatment of Indian kala-azar.
    SEN GUPTA PC; CHAKRAVARTY NK
    Ind Med Gaz; 1946 Nov; 81(11):468-70. PubMed ID: 20287032
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of kala-azar with sodium antimony-v-gluconate; preliminary observations.
    SEN GUPTA PC; CHAKRAVARTY NK
    Ind Med Gaz; 1945 Nov; 80(11):560-4. PubMed ID: 21022523
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.
    Lindoso JAL; Moreira CHV; Celeste BJ; Oyafuso LKM; Folegatti PM; Zijlstra EE
    Rev Soc Bras Med Trop; 2018; 51(1):105-107. PubMed ID: 29513829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of kala-azar associated with post-kala-azar dermal leishmaniasis.
    Sen Gupta PC; Mukherjee AM
    J Indian Med Assoc; 1968 Jan; 50(1):1-5 passim. PubMed ID: 5668350
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-kala-azar dermal leishmaniasis.
    Baghestani S; Handjani F; Sodeifi M; Kumar PV
    Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives].
    WILDE H; DI CARLO FC; PESSAT OA
    Rev Med Cordoba; 1956 Sep; 44():319-31. PubMed ID: 13420979
    [No Abstract]   [Full Text] [Related]  

  • 17. [Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives: personal observation].
    DI CARLO FC; PESSAT OA; WILDE H
    Dia Med; 1956 Nov; 28(84):2629-31; passim. PubMed ID: 13397380
    [No Abstract]   [Full Text] [Related]  

  • 18. The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India.
    Singh N; Chatterjee M; Sundar S
    Parasit Vectors; 2014 Dec; 7():596. PubMed ID: 25515494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stilbamidine in the treatment of Chinese kala-azar, with especial reference to antimony resistant and antimony hypersensitive cases.
    CHUNG HL; CHOW HK; CHANG A; TSAO YP
    Chin Med J; 1951; 69(3-4):171-84. PubMed ID: 14831172
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-kala-azar dermal leishmaniasis: a case report strikingly resembling lepromatous leprosy.
    Ramesh V; Saxena U; Misra RS; Mukherjee A
    Lepr Rev; 1991 Jun; 62(2):217-21. PubMed ID: 1651437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.